An analysis of prescriptions for coronary heart disease with comorbid conditions in health care institutions of Ukraine
Coronary heart disease (CHD) remains the leading cause of mortality among non-communicable diseases in Ukraine and is often accompanied by various comorbid conditions. Providing pharmaceutical care to patients with CHD and comorbid conditions requires a comprehensive approach that includes ensuring...
Saved in:
Main Authors: | N. A. Bilousova, M. M. Dolzhenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2025-03-01
|
Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
Subjects: | |
Online Access: | http://pharmed.zsmu.edu.ua/article/view/320493/314598 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice
by: N. A. Bilousova
Published: (2024-11-01) -
The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine
by: M. M. Dolzhenko, et al.
Published: (2025-06-01) -
INFLUENCE OF SOMATIC COMORBIDITY ON THE COURSE OF CORONARY HEART DISEASE
by: E. B. Akhmedova, et al.
Published: (2017-10-01) -
Marketing analysis of the pharmaceutical market of antidiabetic drugs in Ukraine
by: A. O. Savych, et al.
Published: (2022-04-01) -
Oxidized LDL and Risk of Coronary Heart Disease
by: Luma Abdalmunim Baker
Published: (2023-01-01)